EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS154-01473 
Organism
Homo sapiens 
Tissue/cell
Osteoblast 
Coordinate
chr1:153916930-153918770 
Target genes
Number: 8             
NameEnsembl ID
TF binding sites/motifs
Number: 6             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
JUNMA0488.1chr1:153917218-153917231ATGACATCATTCA-6.41
JUND(var.2)MA0492.1chr1:153917217-153917232CATGACATCATTCAT-6.33
KLF4MA0039.3chr1:153917550-153917561CCACACCCTCC+6.32
ZNF263MA0528.1chr1:153918437-153918458GGAGGAGGCTGAGGAAGGAGC+6.23
ZNF263MA0528.1chr1:153916949-153916970CCCTCCTCTTCCTAGTCCTTC-6.49
ZNF263MA0528.1chr1:153918434-153918455GGGGGAGGAGGCTGAGGAAGG+6.89
Number of super-enhancer constituents: 27             
IDCoordinateTissue/cell
SE_07112chr1:153916510-153920184Brain_Hippocampus_Middle_150
SE_13301chr1:153916379-153919168CD34_Primary_RO01480
SE_13979chr1:153916328-153920017CD34_Primary_RO01536
SE_17279chr1:153916800-153919789CD4p_CD225int_CD127p_Tmem
SE_19751chr1:153916106-153919855CD4p_CD25-_Il17p_PMAstim_Th17
SE_20550chr1:153916049-153920190CD56
SE_22844chr1:153916133-153920212CD8_primiary
SE_27263chr1:153916630-153920158Esophagus
SE_41224chr1:153916145-153919925Left_Ventricle
SE_42677chr1:153916172-153920139Lung
SE_49113chr1:153916189-153919933Right_Atrium
SE_50562chr1:153916550-153920149Sigmoid_Colon
SE_53266chr1:153916690-153920078Small_Intestine
SE_53527chr1:153916236-153920284Spleen
SE_59593chr1:153916527-153921857Ly3
SE_60702chr1:153916094-153937455DHL6
SE_62719chr1:153916077-153937522Tonsil
SE_65739chr1:153916330-153917168Pancreatic_islets
SE_65739chr1:153917349-153918800Pancreatic_islets
SE_68155chr1:153917025-153964411TC32
SE_68156chr1:153917025-153964411TC32
SE_68157chr1:153917025-153964411TC32
SE_68158chr1:153917025-153964411TC32
SE_68159chr1:153917025-153964411TC32
SE_68160chr1:153917025-153964411TC32
SE_68161chr1:153917025-153964411TC32
SE_68162chr1:153917025-153964411TC32
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr1153917018153917841
Enhancer Sequence
CCAGGGTACC CTCTTGCTCC CCTCCTCTTC CTAGTCCTTC CAAAGAAAGG CAGGATAAGG 60
GGTCGGCCAA TCCTGAACTC TTCCCCCTGT GACATCACTG CCCACCACAG CTTCTTAAAG 120
AGACCAGATC CCTCCCACTT AATGGTCCTG GCACTCCCCT CAAAGAACCT AAACTCCACC 180
ACACACAGCT AACCTGAGCT ATGACATTCA CATTGTCCAT GTGTCCCTTT TAAAGGCTCA 240
CCAGTTATAA CATCACAGAG ATCACAATCT TTTTTGTAAT AGCCTTCCAT GACATCATTC 300
ATGCTGGCCA TGACATCATA CCAACCTTAC AGTCTTTTCA AGGGTTTCTG ACCTTCCTAC 360
TCTAGTTATG ACACCATAAG AACCTTGTGA TCCTGCCAAT GTTCTTAAAG AGCCCACTCC 420
TAGGTTTTTA AGAGGACCCC ATGGGTTTCT GAGAAAGCCC ACAAAACCCA AGCTTTAAGA 480
GTCTTTTCAA CGAACCCAAG TGTCCTTTCT CCTAGCTTAA CTCCACCAAT CTGGCCCAAA 540
ATCCAGTGTT CTCACACCTC CAGGATCCTT AGGTAGCTCG TTAGATCCAA AGCAGTTGTG 600
AGAGACAAGT CCCGGCCATC CCACACCCTC CACCATGGAG CCCAGAGACA GAAACAGGCC 660
CACAACAGCC TAGTTCTCAC CTGCCTCCAT GGCCCAACCC CGGGGAGTAG GAGCCCCAAG 720
GGTCCTGAGG CGCCCCAGGG TGCAGAAGCT GGGAAAAAGC CTGGTGGGTA GCTCGCAGCA 780
GGGGCCCAGA AGCGTGGGGG GTGCTTCAGA GGGGAAGGGA GGTTACTTCC TGAAACAGTG 840
GAGGGGAAGC TGCAACTCAG AGGAAGTCAG CCTATGGGTG TGTGTGGTGG CGGTGGCGGT 900
GGTGGGGTTA CCATTGAAGG TGCCAGCACA GCATTACGCC AAGTTGGAAT CTCAGACTAT 960
AGGATCCTGA GCAAGGCAGA GGAGGCTCAG AATGGTTCCA GGATGTGCAG TCCTGCTAAC 1020
CTCCTGCTGT TCCCCCAGAG AACAGGGAAT AAGGAATCTC ATAGAGCCAG GCTGGCTTTC 1080
TTCATCACCT GGCCTCTGGA CACACACACA CACACACACA CGCACACACA CACGCACACA 1140
CGTACACACA CCAACCCCAG CTAAATTTAG ACTCCACTTC TGGGAGGTAA AGCCAGGAGT 1200
CAGCGTCAGC CTCTTGATTT AATTCTGGGG CACAGACCTG TCCCTCATCC ACTGAGGGCG 1260
AATGGGAGCC CTATGCCCAA GGCAGCAGGC AGAGGCCATT AGGTGGGACC TTCTGAGGGG 1320
CAAGTGGGTG GCACCCATCC GCAGGACCTG CGCACCGGGG CCTCCCCTCA CCAAGCCAGG 1380
GAAGAGTCCT GCAGAAAGCA GCCCTTTCTC CCTAGGGAAG ACAACGGGCA CAGGGCCCAC 1440
TCCGGGTCCC CACGCCCGCG TGCCGGGTGA CGGGAAGTTC GGGTTGGGGC AGAGGGCGCG 1500
CCGAGGGGGA GGAGGCTGAG GAAGGAGCAG GAGGGCAGAG AAGCAGGCGC GCCGGCGGCC 1560
GAGGACGTGA CGGCAGCAGC GCCGGCCGCC GCGTGACCCA AGCGGGAGGG AGGGCGGCTC 1620
CGACTCCGGC ACCCACGGGA GCAGAAGGGG GTGCAGGAGG CCGGGCACGG CGAGCTAATT 1680
GCGGGAGGTG CCCTCCCCTC CACTTTCACT TCCCCAGGAG AGAGGAACCG GAACCAGATG 1740
TGCAGTGAGG GACAGCAGCT GGGGGCCATC CCCCACCCCG CCTGCCGCCC GCGCTCCCTC 1800
CTGCCCGTCC CCGCCTGCCG CCCAGCCCGG TCCAGCCCCT 1840